Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Clinical trial NCT00358982 · TERMINATED
Trial details
- NCT number
- NCT00358982
- Sponsor
- Mirati Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-01-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.